<?xml version="1.0" encoding="UTF-8"?>
<ref id="b12">
 <label>12</label>
 <mixed-citation publication-type="journal" publication-format="undefined">
  <name>
   <surname>Cai</surname>
   <given-names>Z</given-names>
  </name>
  <name>
   <surname>Christianson</surname>
   <given-names>AM</given-names>
  </name>
  <name>
   <surname>Ståhle</surname>
   <given-names>L</given-names>
  </name>
  <name>
   <surname>Keisu</surname>
   <given-names>M</given-names>
  </name>
  <article-title>Reexamining transaminase elevation in Phase I clinical trials: the importance of baseline and change from baseline.</article-title>
  <source>Eur J Clin Pharmacol</source>. 
  <year>2009</year>; 
  <volume>65</volume>: 
  <fpage>1025</fpage>–
  <lpage>1035</lpage>. 
  <pub-id pub-id-type="pmid">19554320</pub-id>
 </mixed-citation>
</ref>
